Latest Media Releases

All  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Imugene, Investor Presentation (ASX:IMU)

10 Jan, 2019 09:45 AM

HARNESSING B-CELLS FOR CANCER IMMUNOTHERAPY Investment Highlights Novel immuno-oncology B-cell peptide vaccine technology Outstanding scientific provenance from leading U.S. and European more

Viewing: 1 - 15 of 200  |